written on 05.03.2014

Italy levies eye-opening antitrust fines against Roche, Novartis over Lucentis


Doctors have been prescribing Roche&#39;s cancer drug Avastin off-label to treat some of the same vision problems as its eye drug, Lucentis. Now, Italy&#39;s antitrust authority has fined Roche and marketing partner Novartis,<span style="font-size: 13px;">&nbsp;accusing them of colluding to push doctors toward the pricier option–claims the pair denies.</span>